Meet Aclairo Pharmaceutical Development Group
0Imagine a group of great scientists and all around nice folks who worked with another group for years in dovetailed projects for their clients. It does not take much imagination to wonder why these folks would want to be in one happy group together. On …
Read More
Experimental Pathology Laboratories, Inc. (EPL) Acquires Aclairo Pharmaceutical Development Group, Inc.
EPL and Aclairo Combine Preclinical Services Expertise EPL is pleased to announce that it has acquired Aclairo Pharmaceutical Development Group, Inc. (Aclairo) which provides independent and objective nonclinical, regulatory, and clinical ADME/DMPK expert strategy and implementation to the pharmaceutical and drug device industries. “Aclairo’s team …
Read More-
2015: Year in Review
It certainly was an eventful year at Experimental Pathology Laboratories, Inc. (EPL) again in 2015! Here’s what you may have missed………. EPL continues to add expertise in pathology by establishing a California site headed by Dr. Ted Birkebak in the San Francisco Bay Area to …
Read More
